REQUEST A DEMO
Total
USD $0.00
Search more companies

Admed Pharma Private Limited (India)

Main Activities: Other Services (except Public Administration)
Full name: Admed Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Admed Pharma Private Limited is an unlisted company, incorporated on 30/10/2020. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U36900DL2020PTC372472 and registration number is 372472. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
A-4 Upper Ground Floor Pushpanjli Enclave, Pitampura
North West Delhi; Delhi; Postal Code: 110034

Contact Details: Purchase the Admed Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Admed Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Admed Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Admed Pharma Private Limited report to view the information.
Incorporation Date:
October 30, 2020
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Admed Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
292.45%
Total operating revenue
292.59%
Operating profit (EBIT)
1206.79%
EBITDA
521.66%
Net Profit (Loss) for the Period
1149.95%
Total assets
30.91%
Total equity
1287.23%
Operating Profit Margin (ROS)
3.82%
Net Profit Margin
3.09%
Return on Equity (ROE)
-10.19%
Debt to Equity Ratio
-7060.22%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?